ArticleDiscover oncology2026
Global trends in fertility-preserving treatment for endometrial cancer: a bibliometric analysis, 2005-2024.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveTo quantitatively map and visualize global research trends, key contributors, and thematic evolution in fertility-preserving treatment for endometrial cancer from 2005 to 2024.
methodsResearch publications on fertility-preserving treatment for endometrial cancer were obtained from the Web of Science Core Collection database. We employed CiteSpace and VOSviewer to analyze authors, journals, countries, institutions, citations, references, and keywords.
resultsFrom 2005 to 2024, a total of 1106 publications were published in related fields. Research on fertility-preserving treatment for endometrial cancer progressed rapidly, exhibiting an upward trend in annual publications. China, Fudan University, and Xiaojun Chen were the most productive country, institution, and author, respectively. The journal that published the most articles and received the highest number of citations was Gynecologic Oncology. Keyword co-occurrence analysis identified three major research clusters. These clusters primarily encompass treatment modalities, key clinical outcomes, and risk factors. Molecular classification was a research hotspot from 2021 to 2024.
conclusionThis bibliometric analysis provides insight into current trends and future directions in fertility-preserving treatments for endometrial cancer. Recent research has prominently emphasized molecular classification, with immunotherapy potentially emerging as a promising treatment modality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.